Anthony Mathur

Showing 1-6 of 6 articles

Author Daniel A. Jones

Coronary interventions

An Observational Study assessing the value of Computed Tomography Cardiac Angiography (CTCA) in planning invasive angiographic procedures in patients with previous coronary artery bypass grafting (CABG)

Jones D, Castle EV, Beirne A, Rathod K, Treibel TA, Guttmann O, Moon JC, Smith E, Bourantas C, Davies LC, Wragg A, Pugliese F, Mathur A

June 25, 2019 | 10.4244/EIJ-D-18-01185

Author Christos Bourantas

Interventions for valvular disease

The evolution of device technology in transcatheter aortic valve implantation

Bourantas C, Modolo R, Baumbach A, Søndergaard L, Prendergast B, Ozkor M, Kennon S, Mathur A, Mullen M, Serruys P

April 5, 2019 | 10.4244/EIJ-D-18-01048

Author Rodrigue Stettler

Neointima and neoatherosclerotic characteristics in bare metal and first- and second-generation drug-eluting stents in patients admitted with cardiovascular events attributed to stent failure: an optical coherence tomography study

Stettler R, Dijkstra J, Räber L, Torii R, Zhang Y-J, Karanasos A, Liu S, Crake T, Hamshere S, Garcia-Garcia H, Tenekecioglu E, Ozkor M, Windecker S, Serruys P, Regar E, Mathur A, Bourantas C

February 2, 2018 | 10.4244/EIJ-D-17-00051

Author Andreas Baumbach

Stents and scaffolds

Acute and one-year clinical outcomes following implantation of bioresorbable vascular scaffolds: the ABSORB UK Registry

Baumbach A, Zaman A, West N, O’ Kane P, Egred M, Johnson T, Wheatcroft S, Bowles R, De Belder A, Bouras G, Lansky A, Hill J, Mathur A, De Belder M, Banning A

January 19, 2018 | 10.4244/EIJ-D-17-00886

Author Oliver P. Guttmann

Coronary interventions

Prevalence and outcomes of coronary artery perforation during percutaneous coronary intervention

Guttmann O, Jones D, Gulati A, Kotecha T, Fayed H, Patel D, Crake T, Ozkor M, Wragg A, Smith E, Weerackody R, Knight C, Mathur A, O’Mahony C

August 4, 2017 | 10.4244/EIJ-D-16-01038

Author Daniel A. Jones

The impact of socio-economic status on all-cause mortality after percutaneous coronary intervention: an observational cohort study of 13,770 patients

Jones D, Howard J, Rathod K, Gallagher S, Knight C, Jain A, Mathur A, Mohiddin S, Mills P, Timmis A, Archbold R, Wragg A

February 20, 2015 | 10.4244/EIJV10I10A196

1

Latest news

TAVR in sarcopaenia; CCTA or TEE in LAAC; Iintravascular lithotripsy, read the new issue

(CT scans of a sarcopaenic patient)

October 18, 2019

Medical device regulation in Europe – what is changing and how can I become more involved?

October 18, 2019

New this week: Hydrodynamic function with the ALLEGRA heart valve

October 15, 2019

Guidelines, consensus & position papers

When is it best to stop aspirin and who could ultimately benefit?

Aspirin-free antiplatelet regimens after PCI

October 9, 2019

Last week's JAA's: 3D printing in TAVI, QFR SYNTAX score and non-obstructive disease

October 8, 2019

The EuroIntervention health check 2019

October 4, 2019

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke